Recently, FSP1 has been shown to possess anti-ferroptosis function in various cancers (Gong et al. 2023; Müller et al. 2023; Yang et al. 2022; Zheng et al. 2022), including NSCLC (Kim et al. 2023b; Yuan et al. 2023). This evidence concerns the gene AIFM2 and cancer.